Top Story

FDA panel recommends label changes for Nesina

April 16, 2015

An FDA advisory panel recommended label changes for the diabetes drug Nesina after results from a cardiovascular outcomes trial revealed an increased risk for heart disease.

The Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted 13-3 Tuesday in favor of including new safety information for Nesina (alogliptin, Takeda Pharmaceuticals). The recommendation follows EMDAC review of the results of the EXAMINE trial, which found an increase in the rate of hospitalization for heart failure in patients who were assigned the drug.

FDA News

FDA panel recommends new safety labeling for Onglyza

April 15, 2015
An FDA advisory panel recommended label changes for the diabetes drug Onglyza after results from a cardiovascular outcomes trial revealed an increased risk for heart…
Meeting News Coverage

Glycemic control may improve clopidogrel response in patients with stable CAD

April 10, 2015
SAN DIEGO — In patients with stable CAD, high levels of plasma glucose reduced clopidogrel efficacy, according to data presented at the American College of…
In the Journals

CABG may confer improved survival over PCI in patients with diabetes

April 8, 2015
Among patients with diabetes with CVD in the Coronary Artery Revascularization Evaluation registry, CABG was associated with better long-term survival and reduced risk…
CME
Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

More »
Meeting News Coverage Video
thumbnail for video 3857626096001

Francesco Rubino, MD: 'Converting' bariatric surgery into a diabetes intervention poses challenges

October 24, 2014
BOSTON — Converting a procedure that has been used for years as a weight-loss intervention into a treatment aimed…
More »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
FDA News

FDA panel recommends label changes for Nesina

April 16, 2015
An FDA advisory panel recommended label changes for the diabetes drug Nesina after results from a cardiovascular outcomes trial revealed an increased…
FDA News

FDA panel recommends new safety labeling for Onglyza

April 15, 2015
An FDA advisory panel recommended label changes for the diabetes drug Onglyza after results from a cardiovascular outcomes trial revealed an…
Meeting News Coverage

Glycemic control may improve clopidogrel response in patients with stable CAD

April 10, 2015
SAN DIEGO — In patients with stable CAD, high levels of plasma glucose reduced clopidogrel efficacy, according to data presented at the…
In the Journals

CABG may confer improved survival over PCI in patients with diabetes

April 8, 2015
Among patients with diabetes with CVD in the Coronary Artery Revascularization Evaluation registry, CABG was associated with better long-term…
In the Journals

Diabetes risk higher for middle-aged adults who habitually stay up late

April 1, 2015
Diabetes, metabolic syndrome and sarcopenia were more likely to develop in people who prefer late nights than in early risers, even with the same…
In the Journals

Higher CV risk with acarbose than metformin in type 2 diabetes

March 27, 2015
In the nationwide cohort study, Lee-Ming Chuang, MD, PhD, of Nationwide Taiwan University Hospital, and colleagues evaluated data from the Taiwan…
In the Journals

Updated diabetes care guidelines for PCPs stress importance of individualized treatment

March 23, 2015
Recent updates to the American Diabetes Association’s Standards of Medical Care in Diabetes place an emphasis on individualizing and tailoring…
In the Journals

Diabetes prevalence lower in patients with familial hypercholesterolemia than unaffected relatives

March 11, 2015
Patients with familial hypercholesterolemia had a lower prevalence of type 2 diabetes compared with relatives without familial hypercholesterolemia…
Gabriela Vazquez-Benitez In the Journals

Diabetes, CVD increase rates of CV events

February 27, 2015
Among adults with diabetes, paying extra attention to traditional cardiovascular risk factors could reduce the rates of cardiovascular events and…
Jill Kanaley In the Journals

After-dinner exercise decreases CVD risk in type 2 diabetes

February 19, 2015
Cardiovascular disease risk decreased among obese adults with type 2 diabetes when they exercised after a meal, according to study findings published…
More Headlines »
morganatic-roan